Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lili Mao

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
Frontiers in Oncology|October 29, 2020
The Impact of Liver Metastasis on Anti-PD-1 Monoclonal Antibody Monotherapy in Advanced Melanoma: Analysis of Five Clinical StudiesXuan Wang, Qing Ji, Xieqiao Yan, et al.
Oncology Research|August 5, 2018
Efficacy Evaluation of Imatinib for the Treatment of Melanoma: Evidence From a Retrospective StudyXiaoting Wei, Lili Mao, Zhihong Chi, et al.
Translational Oncology|July 16, 2017
Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose InterferonJiayi Yu, Xiaowen Wu, Huan Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2021
Randomized Phase II Study of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal MelanomaXieqiao Yan, Xinan Sheng, Zhihong Chi, et al.
Journal of Translational Medicine|December 6, 2017
Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapyHuan Yu, Meng Ma, Junya Yan, et al.
Urologic Oncology|July 14, 2020
Clinicopathological characteristics, prognosis, and chemosensitivity in patients with metastatic upper tract urothelial carcinomaXu Li, Siming Li, Zhihong Chi, et al.
Journal of Cancer Research and Clinical Oncology|July 20, 2023
A nomogram incorporating Ki67 to predict survival of acral melanomaYu Du, Caili Li, Lili Mao, et al.
The Oncologist|August 20, 2024
Predominance of hyperprogression in mucosal melanoma during anti-PD-1 monotherapy treatmentLi Zhou, Min Cao, Haibin Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Large-scale analysis of KIT aberrations in Chinese patients with melanomaYan Kong, Lu Si, Yanyan Zhu, et al.
Clinical Genitourinary Cancer|April 7, 2022
Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell CarcinomaXieqiao Yan, Li Zhou, Siming Li, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
Frontiers in Oncology|October 29, 2020
The Impact of Liver Metastasis on Anti-PD-1 Monoclonal Antibody Monotherapy in Advanced Melanoma: Analysis of Five Clinical StudiesXuan Wang, Qing Ji, Xieqiao Yan, et al.
Oncology Research|August 5, 2018
Efficacy Evaluation of Imatinib for the Treatment of Melanoma: Evidence From a Retrospective StudyXiaoting Wei, Lili Mao, Zhihong Chi, et al.
Translational Oncology|July 16, 2017
Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose InterferonJiayi Yu, Xiaowen Wu, Huan Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2021
Randomized Phase II Study of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal MelanomaXieqiao Yan, Xinan Sheng, Zhihong Chi, et al.
Journal of Translational Medicine|December 6, 2017
Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapyHuan Yu, Meng Ma, Junya Yan, et al.
Urologic Oncology|July 14, 2020
Clinicopathological characteristics, prognosis, and chemosensitivity in patients with metastatic upper tract urothelial carcinomaXu Li, Siming Li, Zhihong Chi, et al.
Journal of Cancer Research and Clinical Oncology|July 20, 2023
A nomogram incorporating Ki67 to predict survival of acral melanomaYu Du, Caili Li, Lili Mao, et al.
The Oncologist|August 20, 2024
Predominance of hyperprogression in mucosal melanoma during anti-PD-1 monotherapy treatmentLi Zhou, Min Cao, Haibin Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Large-scale analysis of KIT aberrations in Chinese patients with melanomaYan Kong, Lu Si, Yanyan Zhu, et al.
Clinical Genitourinary Cancer|April 7, 2022
Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell CarcinomaXieqiao Yan, Li Zhou, Siming Li, et al.
Pageof 15